| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eb9667071f40bd09df47436437f0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daeacea876133c9f6d91d38940412e79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d170c226ee9213f0290c14ddcd8dd6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93eb5134029de3861480f79adee00d10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate |
2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5826ee50b627a1173ac64fa899efaed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1d0c0c1dac153e6e55ab652a634ac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71cc0544f0a7c6bec018d6522f610889 |
| publicationDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007014462-A1 |
| titleOfInvention |
Ep4 receptor agonist, compositions and methods thereof |
| abstract |
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts. The compounds of the present invention are the compounds of Formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102498101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106526167-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008149965-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009154190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008136519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106526167-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8648097-B2 |
| priorityDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |